Author: Bill Snyder
Nobel laureate Young to deliver next Flexner Discovery Lecture
Oct. 3, 2018—Michael Young, PhD, a winner of the 2017 Nobel Prize in Physiology or Medicine for his ground-breaking studies of circadian rhythms, will deliver the next Flexner Discovery Lecture at 4 p.m. Oct. 11 in room 208 Light Hall.
Clinic helps adults clarify true status of penicillin allergy
Sep. 27, 2018—by Bill Snyder Two years ago when she was given a type of penicillin to fight off bacterial pneumonia, Kelly Cummins developed a rash, itching and shortness of breath. Suspecting she was having a reaction to the life-saving medication, her doctor stopped the penicillin and substituted a different class of antibiotic. Cummins recovered but now...
Innovative strategies crucial in opioid epidemic response
Sep. 27, 2018—Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.
New histoplasmosis risk map
Sep. 14, 2018—The new mapping approach, called suitability score mapping, should improve public health assessments and interventions for geographic-specific infections.
Research reveals link between immunity, diabetes
Sep. 13, 2018—When it comes to diet-induced obesity, your immune system is not always your friend.
Discovery Lecture to focus on nation’s opioid epidemic
Sep. 6, 2018—Innovative strategies for addressing the nation’s opioid epidemic and its consequences will be discussed during a Cutting-edge Discovery Lecture on Sept. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.
Biomedical sciences journey starts from Simple Beginnings
Sep. 6, 2018—Vanderbilt University School of Medicine welcomed 112 new doctoral students on Aug. 31 during the ninth annual Simple Beginnings ceremony in a Light Hall lecture room filled with family members and other well-wishers.
Team’s findings could spur new treatments for type 2 diabetes
Sep. 6, 2018—An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.
Energetic gene switch
Aug. 30, 2018—New findings link flux through glycolysis, which produces cellular energy, with transcription and gene expression via histone modification.
Team isolates antibodies that neutralize GI bug norovirus
Aug. 30, 2018—Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies that can neutralize norovirus, the leading cause of acute gastrointestinal illness in the world.
Clue to treating obesity found in body’s ‘rheostat’
Aug. 23, 2018—Researchers at Vanderbilt University and the University of Michigan have discovered a critical factor in the rheostatic control of body weight by the brain.
New award honors research by graduate students
Aug. 23, 2018—The Vanderbilt University School of Medicine has established a new award to recognize and support outstanding graduate students who have distinguished themselves through the excellence, significance and scientific rigor of their work.
